Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Gassmann

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Drug Discovery Today|July 30, 2025
Does pharma R&D need a strategic reset? Adapting to a changing US landscapeSebastian Kwisda, Malte Kremer, Niels Sievertsen, et al.
Drug Discovery Today|May 22, 2021
R&D efficiency of leading pharmaceutical companies - A 20-year analysisAlexander Schuhmacher, Lucas Wilisch, Michael Kuss, et al.
Drug Discovery Today|October 9, 2025
The R&D productivity challenge: transforming the pharmaceutical ecosystemAlexander Schuhmacher, Oliver Gassmann, Sebastian Kwisda, et al.
Drug Discovery Today|July 28, 2023
Analysis of pharma R&D productivity - a new perspective neededAlexander Schuhmacher, Markus Hinder, Alexander von Stegmann Und Stein, et al.
Journal of Structural Biology|February 25, 2009
The M34A mutant of Connexin26 reveals active conductance states in pore-suspending membranesOliver Gassmann, Mohamed Kreir, Cinzia Ambrosi, et al.
The Journal of Biological Chemistry|June 3, 2010
Pannexin1 and Pannexin2 channels show quaternary similarities to connexons and different oligomerization numbers from each otherCinzia Ambrosi, Oliver Gassmann, Jennifer N Pranskevich, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Drug Discovery Today|July 30, 2025
Does pharma R&D need a strategic reset? Adapting to a changing US landscapeSebastian Kwisda, Malte Kremer, Niels Sievertsen, et al.
Drug Discovery Today|May 22, 2021
R&D efficiency of leading pharmaceutical companies - A 20-year analysisAlexander Schuhmacher, Lucas Wilisch, Michael Kuss, et al.
Drug Discovery Today|October 9, 2025
The R&D productivity challenge: transforming the pharmaceutical ecosystemAlexander Schuhmacher, Oliver Gassmann, Sebastian Kwisda, et al.
Drug Discovery Today|July 28, 2023
Analysis of pharma R&D productivity - a new perspective neededAlexander Schuhmacher, Markus Hinder, Alexander von Stegmann Und Stein, et al.
Journal of Structural Biology|February 25, 2009
The M34A mutant of Connexin26 reveals active conductance states in pore-suspending membranesOliver Gassmann, Mohamed Kreir, Cinzia Ambrosi, et al.
The Journal of Biological Chemistry|June 3, 2010
Pannexin1 and Pannexin2 channels show quaternary similarities to connexons and different oligomerization numbers from each otherCinzia Ambrosi, Oliver Gassmann, Jennifer N Pranskevich, et al.
Pageof 3